Literature DB >> 10997531

Cervical spondylotic myelopathy: a common cause of spinal cord dysfunction in older persons.

W F Young1.   

Abstract

Cervical spondylotic myelopathy is the most common cause of spinal cord dysfunction in older persons. The aging process results in degenerative changes in the cervical spine that, in advanced stages, can cause compression of the spinal cord. Symptoms often develop insidiously and are characterized by neck stiffness, arm pain, numbness in the hands, and weakness of the hands and legs. The differential diagnosis includes any condition that can result in myelopathy, such as multiple sclerosis, amyotrophic lateral sclerosis and masses (such as metastatic tumors) that press on the spinal cord. The diagnosis is confirmed by magnetic resonance imaging that shows narrowing of the spinal canal caused by osteophytes, herniated discs and ligamentum flavum hypertrophy. Choice of treatment remains controversial, surgical procedures designed to decompress the spinal cord and, in some cases, stabilize the spine are successful in many patients.

Entities:  

Mesh:

Year:  2000        PMID: 10997531

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  71 in total

1.  A Prospective Study of the Functional Outcome of Anterior Cervical Discectomy With Fusion in Single Level Degenerative Cervical Disc Prolapse.

Authors:  Mayur M Kamani; Arjun Ballal; Vikram Shetty; H Ravindranath Rai; Deepak Hegde
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Correlation between the clinic and the index of cervical myelopathy Torg.

Authors:  Agnaldo Rogério Lozorio; Mateus Borges; José Lucas Batista Junior; Charbel Chacob Junior; Igor Cardoso Machado; Rodrigo Rezende
Journal:  Acta Ortop Bras       Date:  2012       Impact factor: 0.513

Review 3.  Comparison of anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy.

Authors:  Jiaquan Luo; Kai Cao; Sheng Huang; Liangping Li; Ting Yu; Cong Cao; Rui Zhong; Ming Gong; Zhiyu Zhou; Xuenong Zou
Journal:  Eur Spine J       Date:  2015-04-04       Impact factor: 3.134

4.  Reproducibility, temporal stability, and functional correlation of diffusion MR measurements within the spinal cord in patients with asymptomatic cervical stenosis or cervical myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Davis C Woodworth; Hajime Yokota; Langston T Holly
Journal:  J Neurosurg Spine       Date:  2018-02-09

5.  Correlation between degree of subvoxel spinal cord compression measured with super-resolution tract density imaging and neurological impairment in cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Davis C Woodworth; Langston T Holly
Journal:  J Neurosurg Spine       Date:  2015-03-06

6.  Clustered clinical findings for diagnosis of cervical spine myelopathy.

Authors:  Chad Cook; Christopher Brown; Robert Isaacs; Matthew Roman; Samuel Davis; William Richardson
Journal:  J Man Manip Ther       Date:  2010-12

7.  Dynamic cervical myelopathy in young adults.

Authors:  Lotfi Hattou; Xavier Morandi; Pierre-Jean Le Reste; Raphaël Guillin; Laurent Riffaud; Pierre-Louis Hénaux
Journal:  Eur Spine J       Date:  2014-04-30       Impact factor: 3.134

8.  Cervical spondylotic myelopathy surgical trial: randomized, controlled trial design and rationale.

Authors:  Zoher Ghogawala; Edward C Benzel; Robert F Heary; K Daniel Riew; Todd J Albert; William E Butler; Fred G Barker; John G Heller; Paul C McCormick; Robert G Whitmore; Karen M Freund; J Sanford Schwartz
Journal:  Neurosurgery       Date:  2014-10       Impact factor: 4.654

9.  [Neck pain. Functional and radiological findings compared with topical pain descriptions].

Authors:  C Krasny; H Tilscher; M Hanna
Journal:  Orthopade       Date:  2005-01       Impact factor: 1.087

10.  Functional outcome of corpectomy in cervical spondylotic myelopathy.

Authors:  Kanishka E Williams; Rajesh Paul; Yashbir Dewan
Journal:  Indian J Orthop       Date:  2009-04       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.